Home » Archive by Category


Reliability Engineer – Jones Lang LaSalle – San Diego, CA

October 22, 2014 – 9:05 am | Edit Post

Also provides detailed design support for non c. Develops and maintains site engineering specifications and standards….
From Jones Lang LaSalle – 22 Oct 2014 16:05:37 GMT
– View all San Diego jobs

BioGPS Featured Article – Correcting for Differential Transcript Coverage Reveals a Strong Relationship between Alternative Splicing and Organism Complexity

October 22, 2014 – 9:00 am | Edit Post

BioGPS has become the valuable resource that it is because of the contributions from our wonderful user community. Thank you […]

Temporary Technology Transfer Agent – Vertex – San Diego, CA

October 22, 2014 – 8:04 am | Edit Post

This individual will participate in the generation of the agreements using legal templates, negotiate terms and conditions with for-profit and non-profit groups…
From DeviceSpace.com – 22 Oct 2014 15:04:50 GMT
– View all San Diego jobs

PipelineRx Announces the Availability of its Telepharmacy Information System (TPIS) Platform to the Healthcare Sector

October 22, 2014 – 7:30 am | Edit Post

SAN FRANCISCO, Oct. 22, 2014 /PRNewswire/ – PipelineRx, a leading medication management services company focused on clinical telepharmacy, today announced the availability of its TPIS platform offering to further address the needs of today’s efficient pharmacy. Since being announced last year, 31 hospitals are currently using the TPIS SaaS platform to bring improved clinical workflow. PipelineRx is the established leader in remote telepharmacy solutions currently partnering with over 200 hospitals to increase the quality of patient care.

PipelineRx TPIS is a SaaS based solution and is designed to provide hospitals with an extremely cost-effective remote platform that facilitates consolidation and provides cost reduction opportunities to hospitals and health systems while enabling a higher quality standard for care.  This web and cloud enabled technology makes it easier for hospital pharmacies to consolidate pharmacy operations by reducing complexity of interoperability, treatment variation, and formulary deviation within a health system, all while driving clinical priorities to ensure economic viability as the market moves from a “fee for service” to a “fee for value” based reimbursement system.  Unique capabilities within the PipelineRx TPIS solution provide larger hospital organizations with tools that are not found in any other solution available today. 

Brian Roberts, PipelineRx’s CEO, notes that clients increasingly face complex labor and workflow challenges within the pharmacy and are looking for technology empowered solutions that streamline workflow, improve efficiency, and reduce operating costs.  “PipelineRx’s software has flawlessly processed more than 5 million medication orders to date, freeing up customers to deploy key resources to improve patient care,” said Roberts. “With a flexible end-to-end solution designed by pharmacists for pharmacists, we now offer the most sophisticated unified process, from the prescription to the dispensing of medications, PipelineRx TPIS provides an ROI that is significant and immediate.”

“For 5 years we have partnered with hospitals to not only facilitate remote medication dispensing, but also evaluate and discover ways existing pharmacists can participate in the drivers of the new outcomes based economy,” said Chuck Dunlap, EVP of Customer Experience at PipelineRx. “Today’s availability of a TPIS solution brings greater flexibility to our industry, allowing better utilization of pharmacy teams and increased productivity without compromising great care.”

For more information, or to schedule an overview and demo of PipelineRx SaaS and software solutions, please contact:

Media Contact:

Chuck Dunlap                                                       

Jessika Parry

EVP of Customer Experience                              

Next Step Communications





To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pipelinerx-announces-the-availability-of-its-telepharmacy-information-system-tpis-platform-to-the-healthcare-sector-203859705.html
SOURCE PipelineRx

Principal Scientist, Process Chemistry – Ardea Biosciences, Inc. – San Diego, CA

October 22, 2014 – 6:28 am | Edit Post

Ardea Biosciences, a San Diego based biotechnology company and subsidiary of Astra. Zeneca, is searching for a Principal Scientist, Process Chemistry to join…
From BioSpace.com – 22 Oct 2014 13:28:40 GMT
– View all San Diego jobs

Paper Pak Industries Release: New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus

October 22, 2014 – 5:00 am | Edit Post

LA VERNE, Calif., Oct. 22, 2014 /PRNewswire/ –Paper Pak Industries, a manufacturer of innovative emergency readiness products, has developed APLS Body Guard Bio, a disposable, highly absorbent body bag that minimizes the spread of bacteria and virus while protecting service providers and the deceased…

Regulus Therapeutics, Inc. Release: A Single Subcutaneous Dose Of 2mg/Kg Of RG-101, Regulus’ Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction As Monotherapy At Day 29 In Patients With Varied HCV Genotypes And Treatment History

October 22, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 22, 2014 /PRNewswire/ –Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical…

BioNano Genomics’s Irys System Adopted By Leading Genomics Centers For Comprehensive Detection Of Human Genome Structural Variation

October 22, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 21, 2014 /PRNewswire/ –BioNano Genomics, the genome mapping company, announced today the latest genomics research centers to purchase an

Biomarker Discovery Company, Antigen Discovery Inc., Awarded An NIH Phase I Small Business Innovation Research Grant To Develop A Pan-HIV Protein Microarray Chip

October 22, 2014 – 5:00 am | Edit Post

IRVINE, Calif., Oct 22, 2014 /PRNewswire/ — Antigen Discovery Inc. (ADi), a privately held company in Irvine, California, announced the receipt of a National Institutes of Health (NIH) Phase I Small Business Innovation Researchaward (SBIR) fromthe National Institute of Dental…

Regulus Therapeutics, Inc. Gets Seat At Hepatitis C Table With Impressive Phase 1 Results; Stock Up 99.98% At 12:54PM ET On Wednesday

October 22, 2014 – 5:00 am | Edit Post